CVE:ZMD ZoomMed Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ZoomMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. C$0.02 +0.02 (+∞) (As of 10/4/2018) Add Compare Share Today's RangeC$0.02▼C$0.0250-Day RangeC$0.02▼C$0.0252-Week RangeC$0.01▼C$0.05Volume220,000 shsAverage Volume290,486 shsMarket CapitalizationC$2.03 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsHeadlinesSocial Media ZoomMed MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.0.22 out of 5 stars 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for ZoomMed. Previous Next 0.0 Short Interest Short InterestThere is no current short interest data available for ZMD. Previous Next 0.0 Dividend Strength Dividend YieldZoomMed does not currently pay a dividend.Dividend GrowthZoomMed does not have a long track record of dividend growth. Previous Next 0.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ZMD. Previous Next 1.1 News and Social Media Coverage News SentimentZoomMed has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Computer and Technology companies. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ZoomMed insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of ZoomMed is -1.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of ZoomMed is -1.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ZMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ZoomMed and its competitors with MarketBeat's FREE daily newsletter. Email Address About ZoomMedZoomMed Inc., together with its subsidiaries, develops and markets a range of computer applications designed for healthcare professionals primarily in the United States and the United Kingdom. The company builds and operates a clinical information exchange platform between physicians, pharmacists, and various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical companies, laboratories, physiotherapy clinics, and other organizations. It also offers ZRx Prescriber, a technological Web application that enables physicians to generate prescriptions. ZoomMed Inc. was incorporated in 2005 and is headquartered in Brossard, Canada.Read More ZMD Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Industry, Sector and Symbol Stock ExchangeCVE Industry Health Information Services Sub-IndustryN/A SectorComputer and Technology Current SymbolCVE:ZMD CUSIPN/A CIKN/A Webzoommedcorpo.com Phone+1-450-6785457FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual SalesC$10,000.00 Price / Sales203.39 Cash FlowN/A Price / Cash FlowN/A Book ValueC($0.02) per share Price / Book-0.88Miscellaneous Outstanding Shares135,591,000Free FloatN/AMarket CapC$2.03 million OptionableNot Optionable BetaN/A ZoomMed Frequently Asked Questions How has ZoomMed's stock performed in 2022? ZoomMed's stock was trading at C$0.02 at the beginning of 2022. Since then, ZMD shares have increased by 0.0% and is now trading at C$0.02. View the best growth stocks for 2022 here. Who are ZoomMed's key executives? ZoomMed's management team includes the following people: Mr. Yves Marmet, Chairman, CEO & PresMs. Marie-Helene Pinard, CFO, VP of Operations & Fin., Sec. and DirectorMr. André Marmet, VP of Corp. Bus. Who are some of ZoomMed's key competitors? Some companies that are related to ZoomMed include IQ-AI (IQAI), CardioComm Solutions (EKG), Sensyne Health (SENS), 1st Group (1ST), Alcidion Group (ALC), Artrya (AYA), Binovi Technologies (BNVIF), Cann American (CNNA), Carebook Technologies (CRBKF), Careteq (CTQ), CloudMD Software & Services (DOCRF), Cogstate (CGS), Corum Group (COO), Dialogue Health Technologies (CARE.TO) and EGF Theramed Health (EVAHF). View all of ZMD's competitors. What is ZoomMed's stock symbol? ZoomMed trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ZMD." How do I buy shares of ZoomMed? Shares of ZMD and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is ZoomMed's stock price today? One share of ZMD stock can currently be purchased for approximately C$0.02. How much money does ZoomMed make? ZoomMed (CVE:ZMD) has a market capitalization of C$2.03 million and generates C$10,000.00 in revenue each year. How can I contact ZoomMed? ZoomMed's mailing address is 8005 du Quartier Blvd Suite 303, BROSSARD, QC J4Y 0N5, Canada. The official website for ZoomMed is zoommedcorpo.com. The company can be reached via phone at +1-450-6785457. This page (CVE:ZMD) was last updated on 7/6/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here